The Effect of Hippotherapy and Medication on Children with Attention Deficit Hyperactivity Disorder: A Pilot Study.
10.4306/jknpa.2015.54.1.112
- Author:
Jihye SONG
1
;
Byongsu JANG
;
Jiwon KIM
;
Jiyoung LEE
;
Hye Yeon SHIN
;
Yunhye OH
;
Kounseok LEE
;
Seonwoo KIM
;
Yun Hee KIM
;
Jeong Yi KWON
;
Yoo Sook JOUNG
Author Information
1. Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. yschoung@skku.edu
- Publication Type:Randomized Controlled Trial ; Original Article
- Keywords:
Attention deficit hyperactivity disorder;
Hippotherapy;
Psychostimulant;
Quantitative electroencephalography
- MeSH:
Attention Deficit Disorder with Hyperactivity*;
Child Behavior;
Child*;
Electroencephalography;
Equine-Assisted Therapy*;
Humans;
Intelligence;
Mood Disorders;
Pilot Projects*
- From:Journal of Korean Neuropsychiatric Association
2015;54(1):112-118
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: This study researched the clinical effects of hippotherapy and medication in attention deficit hyperactivity disorder (ADHD) children. METHODS: The study employed an open label randomized controlled trial. Participants were 10 children of ages between 6 and 12 years. These subjects were placed in 2 groups : the hippotherapy group and the medication group. Evaluation tools used in this study include Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean Version, the Wechsler Intelligence Scale for Children-IV, Korean Child Behavior Check List (K-CBCL), ADHD rating scale (ARS), Clinical Global Impression (CGI), and Quantitative electroencephalography (QEEG). RESULTS: Grossly scores of investigator-administered ADHD rating scale (ARS-I), K-CBCL, and CGI-Severity of Illness scale were improved in both the hippotherapy and the medication group. The ARS-I scores of the Hippotherapy group were not significantly different from baseline after 12 weeks. In the QEEG, theta/beta ratio of Pz area in the hippotherapy group was significantly different from baseline. Children treated with medication showed significant difference from baseline in ARS-I, K-CBCL subscales, and QEEG. CONCLUSION: The use of hippotherapy could be a viable treatment strategy as a part of a multimodal therapy for children with ADHD. This pilot study provides good prospects for future studies to document these positive trends on larger samples.
